RxDoctor Payments Data

Frank Crociata, DO

Family Medicine · Torrington, CTNPI 1497790711

Payments from drug & device makers

$144in general payments, 2019–2025

Across 9 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$46
  • Novo Nordisk$27
  • GSK$17
  • Johnson & Johnson$15
  • Avanir Pharmaceuticals, Inc.$14
  • Pfizer$13
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$9868%
  • Education$4632%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$144 in reported general payments places this provider in the 35th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$80,195
Medicare patients
205
Services billed
846

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide120$145,544
EliquisApixaban91$65,446
JanuviaSitagliptin Phosphate76$63,638
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$39,224
MounjaroTirzepatide31$36,187
TrulicityDulaglutide25$33,710
FarxigaDapagliflozin Propanediol27$25,782
ShingrixVaricella-Zoster Ge/As01b/Pf106$22,901
XareltoRivaroxaban20$22,749
RybelsusSemaglutide22$20,948
LinzessLinaclotide36$20,679
JardianceEmpagliflozin12$14,816
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr23$13,241
Bydureon BciseExenatide Microspheres11$8,957
Breo ElliptaFluticasone/Vilanterol22$8,916

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$27$166,493142 claims
GSKTrelegy Ellipta, Shingrix, Anoro Ellipta, Breo Ellipta$17$84,282201 claims
PfizerEliquis$13$65,44691 claims
AstraZenecaFarxiga, Symbicort$46$32,72853 claims
Johnson & JohnsonXarelto$15$22,74920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 588 family medicine providers in Connecticut.

Other family medicine in Torrington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →